These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 33939245)

  • 1. A low exhaled nitric oxide level excludes a short-term benefit from inhaled corticosteroids in suspected asthma: A randomized placebo-controlled trial.
    Sutherland L; Shaw K; Parrish C; Singleton N; McKeever TM; Stewart I; Shaw D; Martin MJ; Harrison T
    Respirology; 2021 Jul; 26(7):666-672. PubMed ID: 33939245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults.
    Petsky HL; Cates CJ; Li A; Kynaston JA; Turner C; Chang AB
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006340. PubMed ID: 19821360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENOtype trial.
    Anderson WJ; Short PM; Williamson PA; Lipworth BJ
    Chest; 2012 Dec; 142(6):1553-1561. PubMed ID: 23364390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children.
    Ghiro L; Zanconato S; Rampon O; Piovan V; Pasquale MF; Baraldi E
    Eur Respir J; 2002 Sep; 20(3):630-4. PubMed ID: 12358339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of fractional exhaled nitric oxide in predicting response to inhaled corticosteroids in chronic cough: a meta-analysis.
    Ambrosino P; Accardo M; Mosella M; Papa A; Fuschillo S; Spedicato GA; Motta A; Maniscalco M
    Ann Med; 2021 Dec; 53(1):1659-1672. PubMed ID: 34528479
    [No Abstract]   [Full Text] [Related]  

  • 6. Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial.
    Price DB; Buhl R; Chan A; Freeman D; Gardener E; Godley C; Gruffydd-Jones K; McGarvey L; Ohta K; Ryan D; Syk J; Tan NC; Tan T; Thomas M; Yang S; Konduru PR; Ngantcha M; d'Alcontres MS; Lapperre TS
    Lancet Respir Med; 2018 Jan; 6(1):29-39. PubMed ID: 29108938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between fraction of exhaled nitrous oxide, bronchodilator response and inhaled corticosteroid type.
    Smith RW; Downey K; Snow N; Dell S; Smith WG
    Can Respir J; 2015; 22(3):153-6. PubMed ID: 25874734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acinar effect of inhaled steroids evidenced by exhaled nitric oxide.
    Van Muylem A; Kerckx Y; Michils A
    J Allergy Clin Immunol; 2010 Oct; 126(4):730-735.e2. PubMed ID: 20709384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Breathing for Life Trial: a randomised controlled trial of fractional exhaled nitric oxide (FENO)-based management of asthma during pregnancy and its impact on perinatal outcomes and infant and childhood respiratory health.
    Murphy VE; Jensen ME; Mattes J; Hensley MJ; Giles WB; Peek MJ; Bisits A; Callaway LK; McCaffery K; Barrett HL; Colditz PB; Seeho SK; Attia J; Searles A; Doran C; Powell H; Gibson PG
    BMC Pregnancy Childbirth; 2016 May; 16():111. PubMed ID: 27189595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and medium-term effect of inhaled corticosteroids on exhaled breath biomarkers in severe asthma.
    Alahmadi FH; Wilkinson M; Keevil B; Niven R; Fowler SJ
    J Breath Res; 2022 Jul; 16(4):. PubMed ID: 35724643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker-based asthma phenotypes of corticosteroid response.
    Cowan DC; Taylor DR; Peterson LE; Cowan JO; Palmay R; Williamson A; Hammel J; Erzurum SC; Hazen SL; Comhair SAA
    J Allergy Clin Immunol; 2015 Apr; 135(4):877-883.e1. PubMed ID: 25488689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between exhaled nitric oxide, rs28364072 polymorphism of FCER2 gene, asthma control, and inhaled corticosteroid responsiveness in children with asthma.
    Duong-Quy S; Le-Thi-Minh H; Nguyen-Thi-Bich H; Pham-Thu H; Thom VT; Pham-Thi-Hong N; Duong-Thi-Ly H; Nguyen-Huy B; Ngo-Minh X; Nguyen-Thi-Dieu T; Craig TJ
    J Breath Res; 2020 Nov; 15(1):016012. PubMed ID: 33108776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated fractional exhaled nitric oxide (FeNO) is a clinical indicator of uncontrolled asthma in children receiving inhaled corticosteroids.
    Yin SS; Liu H; Gao X
    Int J Clin Pharmacol Ther; 2017 Jan; 55(1):66-77. PubMed ID: 27443657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing Asthma Attacks in Children using Exhaled Nitric Oxide as a biomarker to inform treatment strategy: a randomised trial (RAACENO).
    Turner S; Cotton SC; Emele CD; Thomas R; Fielding S; Gaillard EA; de Jongste JC; Morgan H; Neilson AR; Norrie J; Pijnenburg M; Price D; Thomas M
    Trials; 2019 Oct; 20(1):573. PubMed ID: 31585544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
    Akamatsu T; Shirai T; Kato M; Yasui H; Hashimoto D; Fujisawa T; Tsuchiya T; Inui N; Suda T; Chida K
    Pulm Pharmacol Ther; 2014 Feb; 27(1):52-6. PubMed ID: 23583566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: a randomised controlled trial.
    Pike K; Selby A; Price S; Warner J; Connett G; Legg J; Lucas JS; Peters S; Buckley H; Magier K; Foote K; Drew K; Morris R; Lancaster N; Roberts G
    Clin Respir J; 2013 Apr; 7(2):204-13. PubMed ID: 22747899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management based on exhaled nitric oxide levels adjusted for atopy reduces asthma exacerbations in children: A dual centre randomized controlled trial.
    Petsky HL; Li AM; Au CT; Kynaston JA; Turner C; Chang AB
    Pediatr Pulmonol; 2015 Jun; 50(6):535-43. PubMed ID: 24891337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of fractional exhaled nitric oxide for asthma management in children: A systematic review and meta-analysis.
    Wang X; Tan X; Li Q
    Pediatr Pulmonol; 2020 Aug; 55(8):1936-1945. PubMed ID: 32525611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New method for single-breath fraction of exhaled nitric oxide measurement with improved feasibility in preschool children with asthma.
    Heijkenskjöld-Rentzhog C; Kalm-Stephens P; Nordvall L; Malinovschi A; Alving K
    Pediatr Allergy Immunol; 2015 Nov; 26(7):662-7. PubMed ID: 26184580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker-guided management reduces exacerbations in non-eosinophilic asthma in pregnancy: A secondary analysis of a randomized controlled trial.
    Murphy VE; Porsbjerg CM; Robijn AL; Gibson PG
    Respirology; 2020 Jul; 25(7):719-725. PubMed ID: 31656059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.